In silico analysis and experimental validation of molecular mechanisms of salvianolic acid A-inhibited LPS-stimulated inflammation, in RAW264.7 macrophages

Cell Proliferation

Volumn 46, Issue 5, 2013, Pages 595-605

  Huang, J ^a   Qin, Y ^a   Liu, B ^b   Li, G Y ^c   Ouyang, L ^b   Wang, J H ^a,c  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SHIHEZI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; HEME OXYGENASE 1; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTOPORPHYRIN ZINC; SALVIANOLIC ACID A; SMALL INTERFERING RNA; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFLAMMATION; MACROPHAGE; MOLECULAR DOCKING; MOLECULAR MECHANICS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

AMYLOID BETA-PEPTIDES; ANIMALS; CAFFEIC ACIDS; CELL LINE; CELL SURVIVAL; ENZYMES; INFLAMMATION; INTERLEUKIN-6; LACTATES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; PROTEIN INTERACTION MAPS; PROTOPORPHYRINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84884704818     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12056     Document Type: Article

References (50)

1. Lundberg IE (2000) The role of cytokines, chemokines, and adhesion molecules in the pathogenesis of idiopathic inflammatory myopathies. Curr. Rheumatol. Rep. 2, 216-224.
2. Adams DO, Hamilton TA (1984) The cell biology of macrophage activation. Annu. Rev. Immunol. 2, 283-318.
3. Walsh LJ (2003) Mast cells and oral inflammation. Crit. Rev. Oral Biol. Med. 14, 188-198.
4. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G et al. (1992) Serum levels of cytokines in chronic liver diseases. Gastroenterology 103, 264-274.
5. Coker RK, Laurent GJ (1998) Pulmonary fibrosis: cytokines in the balance. Eur. Respir. J. 11, 1218-1221.
6. Lind L (2003) Circulating markers of inflammation and atherosclerosis. Atherosclerosis 169, 203-214.
7. Bertolini A, Ottani A, Sandrini M (2001) Dual acting anti-inflammatory drugs: a reappraisal. Pharmacol. Res. 44, 437-450.
8. Cheng TO (2007) Cardiovascular effects of Danshen. Int. J. Cardiol. 121, 9-22.
9. Yagi A, Fujimoto K, Tanonaka K, Hirai K, Takeo S (1989) Possible active components of tan-shen (Salvia miltiorrhiza) for protection of the myocardium against ischemia-induced derangements. Planta Med. 55, 51-54.
10. Chang BB, Zhang L, Cao WW, Cao Y, Yang WL, Wang Y et al. (2010) Pharmacokinetic interactions induced by content variation of major water-soluble components of Danshen preparation in rats. Acta Pharmacol. Sin. 31, 638-646.
11. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H et al. (2008) Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol. Ther. 117, 280-295.
12. Lee TY, Mai LM, Wang GJ, Chiu JH, Lin YL, Lin HC (2003) Protective mechanism of Salvia miltiorrhiza on carbon tetrachloride-induced acute hepatotoxicity in rats. J. Pharmacol. Sci. 91, 202-210.
13. Hu YY, Liu CH, Wang RP, Liu C, Liu P, Zhu DY (2000) Protective actions of salvianolic acid A on hepatocyte injured by peroxidation in vitro. World J. Gastroenterol. 6, 402-404.
14. Tang MK, Ren DC, Zhang JT, Du GH (2002) Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 9, 405-409.
15. Fan HY, Fu FH, Yang MY, Xu H, Zhang AH, Liu K (2010) Antiplatelet and antithrombotic activities of salvianolic acid A. Thromb. Res. 126, e17-e22.
16. Zhang YQ, Tang Y, Wu AL, Zhu HB (2010) Salvianolic acid A displays cardioprotective effects in in vitro models of heart hypoxia/reoxygenation injury. J. Asian Nat. Prod. Res. 12, 899-915.
17. Titheradge MA (1998) The enzymatic measurement of nitrate and nitrite. Methods Mol. Biol. 100, 83-91.
18. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T (2009) The SWISS-MODEL Repository and associated resources. Nucleic Acids Res. 37, D387-D392.
19. Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein pharmacology by ligand chemistry. Nat. Biotechnol. 25, 197-206.
20. Li X, Cai HY, Xu JB, Ying SC, Zhang YZ (2009) A mouse protein interactome through combined literature mining with multiple sources of interaction evidence. Amino Acids 38, 1237-1252.
21. Guan Y, Myers CL, Lu R, Lemischka IR, Bult CJ, Troyanskaya OG (2008) A genomewide functional network for the laboratory mouse. PLoS Comput. Biol. 4, e1000165.
22. Wang N, Xu HL, Zhao X, Wen X, Wang FT, Wang SY et al. (2012) Network-based identification of novel connections among apoptotic signaling pathways in cancer. Appl. Biochem. Biotechnol. 167, 621-631.
23. Fu LL, Yang Y, Xu HL, Cheng Y, Wen X, Ouyang L et al. (2013) Identification of novel caspase/autophagy-related gene switch to cell fate decisions in breast cancers. Cell Prolif. 46, 67-75.
24. Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, Thomas V et al. (2009) DOCK 6: combining techniques to model RNA-small molecule complexes. RNA 15, 1219-1230.
25. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, Klebe G et al. (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res. 35, W522-W525.
26. Payne DN (2003) Nitric oxide in allergic airway inflammation. Curr. Opin. Allergy Clin. Immunol. 3, 133-137.
27. Andreakos E, Foxwell B, Feldmann M (2004) Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? Immunol. Rev. 202, 250-265.
28. Moffat FL Jr, Han T, Li ZM, Peck MD, Jy W, Ahn YS et al. (1996) Supplemental L-arginine HCl augments bacterial phagocytosis in human polymorphonuclear leukocytes. J. Cell. Physiol. 168, 26-33.
29. Laskin DL, Pendino KJ (1995) Macrophages and inflammatory mediators in tissue injury. Annu. Rev. Pharmacol. Toxicol. 35, 655-677.
30. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H et al. (1992) Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem. 267, 25934-25938.
31. Hanada T, Yoshimura A (2002) Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13, 413-421.
32. Karin M (1999) The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. J. Biol. Chem. 274, 27339-27342.
33. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J et al. (1997) IKK-1 and IKK-2: cytokine-activated I kappaB kinases essential for NF-kappaB activation. Science 278, 860-866.
34. Bondeson J (1997) The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines. Gen. Pharmacol. 29, 127-150.
35. Otterbein LE (2002) Carbon monoxide: innovative anti-inflammatory properties of an age-old gas molecule. Antioxid. Redox Signal. 4, 309-319.
36. Shapira L, Soskolne WA, Houri Y, Barak V, Halabi A, Stabholz A (1996) Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun. 64, 825-828.
37. Jeong JB, Jeong HJ (2010) Rheosmin, a naturally occurring phenolic compound inhibits LPS-induced iNOS and COX-2 expression in RAW264.7 cells by blocking NF-kappaB activation pathway. Food Chem. Toxicol. 48, 2148-2153.
38. Bosca L, Zeini M, Traves PG, Hortelano S (2005) Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate. Toxicology 208, 249-258.
39. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN (2005) A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity. J. Biol. Chem. 280, 10326-10332.
40. Shinoura N, Yoshida Y, Asai A, Kirino T, Hamada H (1999) Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax. Oncogene 18, 5703-5713.
41. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ et al. (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270, 7420-7426.
42. Chen YR, Meyer CF, Tan TH (1996) Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J. Biol. Chem. 271, 631-634.
43. Motterlini R, Foresti R, Bassi R, Green CJ (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 28, 1303-1312.
44. Lee TS, Tsai HL, Chau LY (2003) Induction of heme oxygenase-1 expression in murine macrophages is essential for the anti-inflammatory effect of low dose 15-deoxy-Delta 12, 14-prostaglandin J2. J. Biol. Chem. 278, 19325-19330.
45. Wiesel P, Foster LC, Pellacani A, Layne MD, Hsieh CM, Huggins GS et al. (2000) Thioredoxin facilitates the induction of heme oxygenase-1 in response to inflammatory mediators. J. Biol. Chem. 275, 24840-24846.
46. Morse D, Pischke SE, Zhou Z, Davis RJ, Flavell RA, Loop T et al. (2003) Suppression of inflammatory cytokine production by carbon monoxide involves the JNK pathway and AP-1. J. Biol. Chem. 278, 36993-36998.
47. Suh GY, Jin Y, Yi AK, Wang XM, Choi AM (2006) CCAAT/enhancer-binding protein mediates carbon monoxide-induced suppression of cyclooxygenase-2. Am. J. Respir. Cell Mol. Biol. 35, 220-226.
48. Oh GS, Pae HO, Choi BM, Chae SC, Lee HS, Ryu DG et al. (2004) 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2, 3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem. Biophys. Res. Commun. 320, 1156-1162.
49. Ryter SW, Alam J, Choi AM (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 86, 583-650.
50. Ma W, Lim W, Gee K, Aucoin S, Nandan D, Kozlowski M et al. (2001) The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276, 13664-13674.